Susann Szmania

2.6k total citations
40 papers, 1.5k citations indexed

About

Susann Szmania is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Susann Szmania has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 16 papers in Hematology and 14 papers in Molecular Biology. Recurrent topics in Susann Szmania's work include Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (18 papers) and Multiple Myeloma Research and Treatments (14 papers). Susann Szmania is often cited by papers focused on Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (18 papers) and Multiple Myeloma Research and Treatments (14 papers). Susann Szmania collaborates with scholars based in United States, Switzerland and Singapore. Susann Szmania's co-authors include Frits van Rhee, Bart Barlogie, Guido Tricot, John D. Shaughnessy, Tarun K. Garg, Amberly Moreno, Jumei Shi, Katie Stone, Fenghuang Zhan and Priyangi A. Malaviarachchi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Susann Szmania

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susann Szmania United States 17 994 850 590 394 111 40 1.5k
Stefan Wirths Germany 17 1.2k 1.2× 575 0.7× 219 0.4× 601 1.5× 77 0.7× 55 1.6k
Takahiro Shima Japan 14 643 0.6× 491 0.6× 650 1.1× 541 1.4× 92 0.8× 59 1.5k
Cornelis A.M. van Bergen Netherlands 20 949 1.0× 480 0.6× 622 1.1× 232 0.6× 92 0.8× 53 1.3k
Willemijn Hobo Netherlands 26 1.5k 1.5× 1.3k 1.6× 322 0.5× 520 1.3× 79 0.7× 50 2.2k
Eric Braakman Netherlands 24 801 0.8× 421 0.5× 329 0.6× 279 0.7× 114 1.0× 63 1.3k
Il‐Kang Na Germany 22 594 0.6× 437 0.5× 520 0.9× 374 0.9× 122 1.1× 69 1.4k
Ruth Seggewiss Germany 16 567 0.6× 374 0.4× 722 1.2× 322 0.8× 137 1.2× 26 1.4k
Volker L. Reichardt Germany 20 1.7k 1.7× 735 0.9× 402 0.7× 897 2.3× 67 0.6× 31 2.2k
GJ Freeman United States 12 1.1k 1.1× 602 0.7× 329 0.6× 220 0.6× 75 0.7× 15 1.6k
Tadafumi Iino Japan 17 576 0.6× 290 0.3× 566 1.0× 638 1.6× 64 0.6× 39 1.5k

Countries citing papers authored by Susann Szmania

Since Specialization
Citations

This map shows the geographic impact of Susann Szmania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susann Szmania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susann Szmania more than expected).

Fields of papers citing papers by Susann Szmania

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susann Szmania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susann Szmania. The network helps show where Susann Szmania may publish in the future.

Co-authorship network of co-authors of Susann Szmania

This figure shows the co-authorship network connecting the top 25 collaborators of Susann Szmania. A scholar is included among the top collaborators of Susann Szmania based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susann Szmania. Susann Szmania is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lapteva, Natalia, Susann Szmania, Frits van Rhee, & Cliona M. Rooney. (2014). Clinical Grade Purification and Expansion of Natural Killer Cells. Critical Reviews™ in Oncogenesis. 19(1-2). 121–132. 62 indexed citations
2.
Rhee, Frits van, Yi‐Chang Liu, & Susann Szmania. (2014). Profile of elotuzumab and its potential in the treatment of multiple myeloma. PubMed. 2014(4). 15–15. 24 indexed citations
3.
Stone, Katie, Susann Szmania, Owen Stephens, et al.. (2013). Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels. PLoS ONE. 8(1). e54610–e54610. 41 indexed citations
4.
Lapteva, Natalia, April Durett, Jiali Sun, et al.. (2012). Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. 14(9). 1131–1143. 171 indexed citations
5.
Garg, Tarun K., Susann Szmania, Junaid Khan, et al.. (2012). Highly activated and expanded natural killer cells for multiple myeloma immunotherapy. Haematologica. 97(9). 1348–1356. 82 indexed citations
6.
Stone, Katie L., Susann Szmania, Owen Stephens, et al.. (2011). Prevalence of interleukin-6 receptor polymorphism in Castleman disease and association with increased soluble interleukin-6 receptor levels.. Journal of Clinical Oncology. 29(15_suppl). 8077–8077. 2 indexed citations
7.
Moreno-Bost, Amberly, Susann Szmania, Katie Stone, et al.. (2010). Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103. Cytotherapy. 13(5). 618–628. 27 indexed citations
8.
9.
Rhee, Frits van, Katie Stone, Susann Szmania, Bart Barlogie, & Zeba N. Singh. (2010). Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.. PubMed. 8(7). 486–98. 115 indexed citations
10.
Rhee, Frits van, Susann Szmania, Myles Dillon, et al.. (2009). Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. Molecular Cancer Therapeutics. 8(9). 2616–2624. 142 indexed citations
11.
Garg, Tarun K., Susann Szmania, Katie Stone, et al.. (2009). Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo.. Blood. 114(22). 953–953. 1 indexed citations
12.
Garg, Tarun K., Susann Szmania, Jumei Shi, et al.. (2008). Ex Vivo Activated Natural Killer (NK) Cells from Myeloma Patients Kill Autologous Myeloma and Killing Is Enhanced by Elotuzumab. Blood. 112(11). 3666–3666. 3 indexed citations
13.
Shi, Jumei, Guido Tricot, Tarun K. Garg, et al.. (2007). Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma. Blood. 111(3). 1309–1317. 142 indexed citations
14.
Szmania, Susann, Qing Yi, Michele Cottler‐Fox, et al.. (2005). Clinical-grade myeloma Ag pre-loaded DC vaccines retain potency after cryopreservation. Cytotherapy. 7(4). 374–384. 7 indexed citations
15.
Szmania, Susann, Michele Cottler‐Fox, Sanjaya Viswamitra, et al.. (2004). A Novel Strategy for Combining Immunotherapy with High Dose Chemotherapy and Auto-Transplantation in High Risk Multiple Myeloma.. Blood. 104(11). 2920–2920. 2 indexed citations
16.
Musk, Philip, Susann Szmania, Joel Gatlin, et al.. (2001). In Vitro Generation of Epstein-Barr Virus–Specific Cytotoxic T Cells in Patients Receiving Haplo-Identical Allogeneic Stem Cell Transplantation. Journal of Immunotherapy. 24(4). 312–322. 3 indexed citations
17.
Szmania, Susann, Carolyn A. Keever-Taylor, & Lee Ann Baxter‐Lowe. (1997). Automated Nucleotide Sequencing Reveals Substantial Disparity Between the HLA-A2 Genes of Bone Marrow Transplant Recipients and Donors. Human Immunology. 56(1-2). 77–83. 4 indexed citations
18.
Szmania, Susann & Lee Ann Baxter‐Lowe. (1997). Corrected nucleotide sequences for HLA‐A*2901 and HLA‐A*3301. Tissue Antigens. 50(2). 205–206. 3 indexed citations
19.
Szmania, Susann, et al.. (1997). Nucleotide sequence of HLA‐B*5505, which expresses a unique HLA class I polymorphism. Tissue Antigens. 49(5). 537–539. 6 indexed citations
20.
Szmania, Susann & Lee Ann Baxter‐Lowe. (1996). Nucleotide sequence for HLA‐A*2608 which encodes glutamine at codon 156. Tissue Antigens. 48(3). 210–212. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Wirths Breakdown of academic impact, for papers by Takahiro Shima Breakdown of academic impact, for papers by Cornelis A.M. van Bergen Breakdown of academic impact, for papers by Willemijn Hobo Breakdown of academic impact, for papers by Eric Braakman Breakdown of academic impact, for papers by Il‐Kang Na Breakdown of academic impact, for papers by Ruth Seggewiss Breakdown of academic impact, for papers by Volker L. Reichardt Breakdown of academic impact, for papers by GJ Freeman Breakdown of academic impact, for papers by Tadafumi Iino
Rankless by CCL
2026